Lorra Garey1, Brooke Y Kauffman1, Clayton Neighbors1, Norman B Schmidt2, Michael J Zvolensky3. 1. Department of Psychology, University of Houston, Houston, TX, United States. 2. Department of Psychology, Florida State University, Tallahassee, FL, United States. 3. Department of Psychology, University of Houston, Houston, TX, United States; Department of Behavioral Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: mjzvolen@central.uh.edu.
Abstract
INTRODUCTION: Pre-treatment attrition and perceived barriers for quitting are clinically important processes involved in early phases of quitting smoking. However, less is known about the constructs that may contribute to these processes such as negative affect reduction smoking motives. METHOD: The current study sought to evaluate the relation between negative affect reduction smoking motives and pre-treatment attrition and perceived barriers for quitting in a sample of 425 treatment-seeking smokers (48.5% female; Mage=37.69 years; SD=13.61) enrolled in a smoking cessation study examining the efficacy of a transdiagnostic panic-smoking cessation treatment relative to a standard smoking cessation treatment. RESULTS: Results indicated that greater negative affect reduction smoking motives was associated with an increased likelihood of treatment initiation (odds ratio=1.49, CI: 1.09, 2.04). Additionally, negative affect reduction smoking motives was associated with greater perceived barriers for cessation among pre-treatment drop-outs and treatment initiators. CONCLUSIONS: This initial investigation provides evidence for the possible clinical utility in addressing negative affect reduction smoking motives during early stages of quitting. Additionally, such findings could potentially inform the development of personalized, early stages of quitting interventions for smoking cessation.
INTRODUCTION: Pre-treatment attrition and perceived barriers for quitting are clinically important processes involved in early phases of quitting smoking. However, less is known about the constructs that may contribute to these processes such as negative affect reduction smoking motives. METHOD: The current study sought to evaluate the relation between negative affect reduction smoking motives and pre-treatment attrition and perceived barriers for quitting in a sample of 425 treatment-seeking smokers (48.5% female; Mage=37.69 years; SD=13.61) enrolled in a smoking cessation study examining the efficacy of a transdiagnostic panic-smoking cessation treatment relative to a standard smoking cessation treatment. RESULTS: Results indicated that greater negative affect reduction smoking motives was associated with an increased likelihood of treatment initiation (odds ratio=1.49, CI: 1.09, 2.04). Additionally, negative affect reduction smoking motives was associated with greater perceived barriers for cessation among pre-treatment drop-outs and treatment initiators. CONCLUSIONS: This initial investigation provides evidence for the possible clinical utility in addressing negative affect reduction smoking motives during early stages of quitting. Additionally, such findings could potentially inform the development of personalized, early stages of quitting interventions for smoking cessation.
Authors: J K Ockene; K M Emmons; R J Mermelstein; K A Perkins; D S Bonollo; C C Voorhees; J F Hollis Journal: Health Psychol Date: 2000-01 Impact factor: 4.267
Authors: Julia D Buckner; Samantha G Farris; Michael J Zvolensky; Sonia M Shah; Adam M Leventhal; Jennifer A Minnix; Norman B Schmidt Journal: Am J Drug Alcohol Abuse Date: 2014-11-14 Impact factor: 3.829
Authors: Megan E Piper; Thomas M Piasecki; E Belle Federman; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker Journal: J Consult Clin Psychol Date: 2004-04
Authors: Timothy B Baker; Robin Mermelstein; Linda M Collins; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore Journal: Ann Behav Med Date: 2011-04
Authors: Brittain L Mahaffey; Adam Gonzalez; Samantha G Farris; Michael J Zvolensky; Evelyn J Bromet; Benjamin J Luft; Roman Kotov Journal: Nicotine Tob Res Date: 2015-08-24 Impact factor: 4.244
Authors: R Kathryn McHugh; Victoria R Votaw; Francesca Fulciniti; Hilary S Connery; Margaret L Griffin; Peter M Monti; Roger D Weiss Journal: J Subst Abuse Treat Date: 2016-12-30
Authors: Michael J Zvolensky; Lorra Garey; Nicolas P Allan; Samantha G Farris; Amanda M Raines; Jasper A J Smits; Brooke Y Kauffman; Kara Manning; Norman B Schmidt Journal: J Consult Clin Psychol Date: 2018-05